ZA824233B - Therapeutic method and method for making compositions for use therein - Google Patents

Therapeutic method and method for making compositions for use therein

Info

Publication number
ZA824233B
ZA824233B ZA824233A ZA824233A ZA824233B ZA 824233 B ZA824233 B ZA 824233B ZA 824233 A ZA824233 A ZA 824233A ZA 824233 A ZA824233 A ZA 824233A ZA 824233 B ZA824233 B ZA 824233B
Authority
ZA
South Africa
Prior art keywords
making compositions
therapeutic
therapeutic method
compositions
making
Prior art date
Application number
ZA824233A
Other languages
English (en)
Inventor
W Thomas
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of ZA824233B publication Critical patent/ZA824233B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA824233A 1981-06-25 1982-06-16 Therapeutic method and method for making compositions for use therein ZA824233B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/277,469 US4382083A (en) 1981-06-25 1981-06-25 Therapeutic method for treating blood-clotting defects with factor VIIa

Publications (1)

Publication Number Publication Date
ZA824233B true ZA824233B (en) 1983-04-27

Family

ID=23061015

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824233A ZA824233B (en) 1981-06-25 1982-06-16 Therapeutic method and method for making compositions for use therein

Country Status (11)

Country Link
US (1) US4382083A (de)
EP (1) EP0082182B1 (de)
JP (1) JPS58500994A (de)
BR (1) BR8207762A (de)
CA (1) CA1186994A (de)
DE (1) DE3276849D1 (de)
ES (1) ES8304800A1 (de)
IT (1) IT1163004B (de)
MX (1) MX7191E (de)
WO (1) WO1983000016A1 (de)
ZA (1) ZA824233B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501731A (en) * 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
ZA862768B (en) 1985-04-17 1986-12-30 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
AU593042B2 (en) * 1985-11-26 1990-02-01 Novo Nordisk Health Care Ag Compositions and methods for the treatment of bleeding disorders
US6013531A (en) * 1987-10-26 2000-01-11 Dade International Inc. Method to use fluorescent magnetic polymer particles as markers in an immunoassay
FR2632524B1 (fr) * 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
US5677160A (en) * 1989-10-30 1997-10-14 Henkel Corporation Fat splitting process
US5597799A (en) * 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US20040072757A1 (en) * 1990-09-04 2004-04-15 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US5843442A (en) * 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
HUT67693A (en) * 1991-10-11 1995-04-28 Novo Nordisk As Hemostatic composition for arresting local bleedings
DE69306389T2 (de) * 1992-06-12 1997-06-26 Dow Chemical Co Intelligentes prozesssteuerverbindungssystem und verfahren.
CA2220448A1 (en) * 1995-05-31 1996-12-05 Henkel Corporation Improved fat-splitting process
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
EP0796623B1 (de) * 1996-03-20 2005-05-25 Baxter Aktiengesellschaft Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
US20050032690A1 (en) * 1997-09-10 2005-02-10 Rojkjaer Lisa Payne Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
JP4676585B2 (ja) * 1999-12-24 2011-04-27 一般財団法人化学及血清療法研究所 血液凝固異常に基づく疾患の治療・予防用医薬組成物
US7015194B2 (en) * 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
US20030119743A1 (en) * 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
EP1446150A1 (de) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmazeutische zusammensetzung mit faktor-vii- polypeptiden und protein-c-inhibitoren
JP2005510513A (ja) 2001-11-09 2005-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドおよびｔａｆｉポリペプチドを含む薬学的組成物
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
KR20040065278A (ko) * 2001-12-21 2004-07-21 노보 노르디스크 에이/에스 변경된 인자 ⅶ 폴리펩티드의 액체 조성물
EP1458408B1 (de) 2001-12-21 2009-04-15 Novo Nordisk Health Care AG Flüssige zusammensetzung aus faktor vii polypeptiden
US20030186862A1 (en) * 2002-04-02 2003-10-02 Nelsestuen Gary L. Factor VIIa compositions
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
EP1517698B2 (de) 2002-06-21 2017-12-06 Novo Nordisk Health Care AG STABILISIERTE FESTE ZUSAMMENSETZUNGEN VON FAKTOR VIIa POLYPEPTIDEN
JP2006524195A (ja) * 2003-03-18 2006-10-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドの液状水性医薬組成物
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
WO2004103398A1 (en) * 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
ATE446768T1 (de) * 2003-07-01 2009-11-15 Novo Nordisk Healthcare Ag Flüssige wässrige pharmazeutische zusammnesetzung von factor vii polypeptiden
EP1656158B1 (de) 2003-08-14 2016-03-09 Novo Nordisk Health Care AG Flüssige, wässrige pharmazeutische zusammensetzung von faktor-vii-polypeptiden
EP2298287B1 (de) * 2003-12-19 2018-04-11 Novo Nordisk Health Care AG Stabilisierte Zusammensetzungen von Faktor-VII-Polypeptiden
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions

Also Published As

Publication number Publication date
ES513485A0 (es) 1983-04-01
EP0082182A4 (de) 1983-11-09
WO1983000016A1 (en) 1983-01-06
DE3276849D1 (en) 1987-09-03
JPH0428690B2 (de) 1992-05-15
JPS58500994A (ja) 1983-06-23
EP0082182B1 (de) 1987-07-29
IT1163004B (it) 1987-04-08
BR8207762A (pt) 1983-05-31
EP0082182A1 (de) 1983-06-29
US4382083A (en) 1983-05-03
IT8222056A0 (it) 1982-06-24
CA1186994A (en) 1985-05-14
ES8304800A1 (es) 1983-04-01
MX7191E (es) 1987-12-23

Similar Documents

Publication Publication Date Title
ZA824233B (en) Therapeutic method and method for making compositions for use therein
GB2074026B (en) Method and composition for reducing pain
DE3369465D1 (en) Bone-equivalent and method for preparation thereof
ZA828876B (en) Non-staling gum composition and method of preparation
JPS57158715A (en) Skin treatment composition
DE3273329D1 (en) Analgesic process and composition
IL67022A (en) 2-halo-3-chloro-5-haloalkylpyridines and process for their preparation
ZA822487B (en) Analgetic compositions and methods of use
JPS57183724A (en) Medicinal composition and manufacture
DE3373623D1 (en) Pharmaceutical combination composition and associated method
JPS57149230A (en) Medicinal composition
PT75889B (en) Therapeutic agent
GB2090599B (en) Stabilized plasmin compositions and method for preparation thereof
DE3370796D1 (en) Alpha-iminodiacetonitriles and methods for their preparation
DE3272452D1 (en) Medicinal composition and method of making same
DE3264841D1 (en) 4-chloro-4-chloromethyloxetan-2-one and process for its preparation
JPS57156357A (en) Sulfur-aggregate composition and manufacture
DE3162049D1 (en) Method for the preparation of 2-halo-3-sulfonyl-acrylonitriles and their use
DE3374560D1 (en) Cyanoalkylpiperazines and methods for their preparation and use
DE3265462D1 (en) Pharmaceutical mixture and method for making the mixture
DE3170230D1 (en) Therapeutic agent
JPS57139070A (en) Medicinal composition
ZA838867B (en) Fermentation method and composition for use therein
DE3275159D1 (en) Brush and method for its manufacture
ZA825684B (en) New o-alkyl-o-carbamoylglycerophospho-cholines and process for their preparation